These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3048545)

  • 1. [The extension of deep venous thrombosis treated by intravenous heparin: apropos of 12 cases].
    Serradimigni A
    Bull Acad Natl Med; 1988 Mar; 172(3):355-61. PubMed ID: 3048545
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients].
    Lévesque H; Cailleux N; Vasse D; Legallicier B; Moore N; Borg JY; Hantute N; Thuillez C; Courtois H
    Therapie; 1994; 49(2):101-5. PubMed ID: 7817331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Continuous heparin therapy in deep venous thrombosis and its monitoring with the Howel and thrombin times. Prospective study].
    Lozano Sánchez F; Almazán Enríquez A; Ramos Boyero M; del Villar Galán JL; Gómez Alonso A
    Angiologia; 1981; 33(5):272-82. PubMed ID: 7325396
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of streptokinase preparations in experimental deep venous thrombosis].
    Bogomolova LG; Dembo MA; Osipov SN
    Probl Gematol Pereliv Krovi; 1973 Dec; 18(12):13-7. PubMed ID: 4789364
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of deep venous thrombosis with fixed doses of subcutaneous heparin. Preliminary results].
    Lastória S; Maffei FH; Rollo HA; Yoshida WB; Castiglia V; Lorenzi LC; Lintz JA; Sanchez MA
    AMB Rev Assoc Med Bras; 1983; 29(11-12):188-90. PubMed ID: 6608754
    [No Abstract]   [Full Text] [Related]  

  • 6. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response.
    Robertson BR
    Acta Chir Scand Suppl; 1971; 421():1-51. PubMed ID: 5292287
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activation of the endogenous fibrinolytic system using intra-arterial heparin therapy in acute deep venous thrombosis].
    Fontányi S
    Phlebologie; 1990; 43(1):167-72. PubMed ID: 2353043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of streptokinase and heparin on patients with deep venous thrombosis. A coded examination.
    Robertson BR; Nilsson IM; Nylander G; Olow B
    Acta Chir Scand; 1967; 133(3):205-15. PubMed ID: 6030168
    [No Abstract]   [Full Text] [Related]  

  • 10. Deep venous thrombosis treated with a standard dosage of streptokinase.
    Olow B; Johanson C; Andersson J; Eklöf B
    Acta Chir Scand; 1970; 136(3):181-9. PubMed ID: 5518309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological treatment of deep venous trombosis in the aged patient].
    Almazan Enriquez A; Gómez Alonso A; García García J; Ramos Boyero M; Del Villar Galan JL
    Angiologia; 1980; 32(3):118-23. PubMed ID: 6154433
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
    Schiele F; Lindgaerde F; Eriksson H; Bassand JP; Wallmark A; Hansson PO; Grollier G; Sjo M; Moia M; Camez A; Smyth V; Walker M
    Thromb Haemost; 1997 May; 77(5):834-8. PubMed ID: 9184388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous heparin in the treatment of deep venous thrombosis in pregnancy].
    Tanbo T; Servoll T; Hansen LJ; Moe N
    Tidsskr Nor Laegeforen; 1988 May; 108(15):1203-4. PubMed ID: 3388348
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ambulatory treatment of deep venous thrombosis with Fraxiparin. Study of 58 cases].
    Bellenger L
    J Mal Vasc; 1990; 15(4):399-400. PubMed ID: 2286825
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcutaneous or intravenous heparin for deep vein thrombosis.
    Bounameaux H; Krahenbuhl B
    Br Med J (Clin Res Ed); 1987 Jun; 294(6588):1690-1. PubMed ID: 3113593
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin in deep venous thrombosis of the leg--effectiveness and safety].
    Gatterer E; Stöllberger C; Slany J; Stöberl C; Jaksch J
    Wien Klin Wochenschr; 1988 Sep; 100(18):601-5. PubMed ID: 3188535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of postoperative deep vein thrombosis with small doses of heparin].
    Kettunen K; Poikolainen E; Karjalainen P; Oksala I; Alhava E; Rehnberg V; Huttunen H; Mattila M
    Duodecim; 1974; 90(11):834-8. PubMed ID: 4426267
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.